Handelsavisen
prelaunch
Companies Healthcare CHEC.BO
CH
CHEC.BO BSE (India) Pharmaceuticals

Chec.Bo

$91,62
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,07 %
Op margin
8,6 %
ROE
5,2 %
Net margin
5,6 %
Debt / equity
0,57
Beta
52w range
Volume
Day range
Prev close
$10,11
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

CHEC.BO operates in the Pharmaceuticals industry, focusing on the development and commercialization of pharmaceutical products.

Business. Chenghe Acquisition III Co (CHEC.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. No specific operating segments or geographic breakdowns are provided in the available data. The company is headquartered in the United States, consistent with its NASDAQ listing.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
5,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CHEC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CHEC.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Chenghe Acquisition III Co (CHEC.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. No specific operating segments or geographic breakdowns are provided in the available data. The company is headquartered in the United States, consistent with its NASDAQ listing.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    AI synthesis
    GENERATED

    CHEC.BO has a debt-to-equity ratio of 0.57, indicating a moderate level of leverage, and a current ratio of 2.31, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -27.53 million INR, and its capital expenditure is -83.96 million INR, indicating significant investment in long-term assets. The company's liquidity position is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt.

    In terms of profitability, CHEC.BO's return on equity is 5.24%, and its return on assets is 3.08%. These figures suggest that the company is generating a modest return on its equity and assets, which is below the typical performance of industry leaders. The operating margin, calculated as operating income divided by revenue, is 8.60%, and the net profit margin is 5.59%. These margins are relatively low, indicating that the company may be facing competitive pressures or cost inefficiencies.

    The company's revenue is concentrated in a single segment, as no specific segments are disclosed in the available data. There is no detailed geographic breakdown provided, but the company's operations are likely centered in its home market. The lack of segment and geographic diversification could pose a concentration risk, as the company's performance is heavily dependent on a single market or product line.

    Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific outlook figures for the current or next fiscal year, but the negative free cash flow and significant capital expenditure suggest that the company is investing heavily in its operations. This investment could be a sign of expansion or modernization, but it also indicates that the company is not currently generating enough cash to sustain its operations without external financing.

    The risk assessment for CHEC.BO highlights a medium liquidity risk and a low dilution risk. The company's liquidity position is constrained by its negative net cash position after accounting for total debt, which could limit its ability to meet short-term obligations without additional financing. The dilution risk is low, indicating that the company is not expected to issue a significant number of new shares in the near term. However, the company's capital structure and financial flexibility should be closely monitored, as the current leverage and cash flow dynamics could change with market conditions or strategic decisions.

    Recent events and filings do not provide specific details on the company's recent activities or strategic initiatives. The lack of detailed information on recent events or strategic moves makes it challenging to assess the company's current direction and potential for growth. Investors and analysts should look for more detailed disclosures in future filings to better understand the company's strategic priorities and financial health.

    Key takeaways
    • CHEC.BO has a moderate level of leverage with a debt-to-equity ratio of 0.57 and a current ratio of 2.31.
    • The company's return on equity and return on assets are 5.24% and 3.08%, respectively, indicating modest profitability.
    • CHEC.BO's revenue and operations are concentrated in a single segment, posing a concentration risk.
    • The company is investing heavily in capital expenditures, with a negative free cash flow of -27.53 million INR.
    • The liquidity risk is assessed as medium, and the dilution risk is low, suggesting the company is not expected to issue a significant number of new shares in the near term.
    • Recent events and strategic initiatives are not detailed in the available data, making it difficult to assess the company's current direction.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $91,62
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $746.2M
    Net cash
    -$423.0M
    Current ratio
    2.3
    Debt / equity
    0.6
    ROA
    3.1%
    ROE
    5.2%
    Cash conversion
    194.0%
    CapEx / revenue
    -12.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin8,6 %Above median
    Net Margin5,6 %Above median
    ROE5,2 %Above median
    Capex / Rev-12,0 %Below median
    D/E0,57Below median
    Cash Conv1,94Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • CHEC.BO Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Girish ShahExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    1.2Kshares short+27.9% vs prior
    1days to cover
    1fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CHEC.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 2,735.8%Derived (calculated)
    • Return on equity (FY 2025-12-31): -24.6%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -58,250.2%Derived (calculated)
    • Return on assets (FY 2025-12-31): 0.8%Derived (calculated)
    • Current ratio (FY 2025-12-31): 4.53xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): -1.18xDerived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 72,543.6%Derived (calculated)
    • Operating cash flow (annual): USD -189.9KSEC XBRL filing
    • Current assets (annual): USD 808.55KSEC XBRL filing
    • Total assets (annual): USD 128.68MSEC XBRL filing
    • Operating income (annual): USD -281.68KSEC XBRL filing
    • Net income (annual): USD 1.09MSEC XBRL filing
    • Cash & equivalents (annual): USD 696.83KSEC XBRL filing
    • Total liabilities (annual): USD 5.24MSEC XBRL filing
    • Current liabilities (annual): USD 178.5KSEC XBRL filing
    • Shareholders' equity (annual): USD -4.43MSEC XBRL filing
    • Current ratio (FY 2024-12-31): 0.14xDerived (calculated)
    • Debt-to-equity (FY 2024-12-31): -24.33xDerived (calculated)
    • Current assets (annual): USD 25KSEC XBRL filing
    • Total liabilities (annual): USD 184.73KSEC XBRL filing
    • Shareholders' equity (annual): USD -7.59KSEC XBRL filing
    • Current liabilities (annual): USD 184.73KSEC XBRL filing
    • Total assets (annual): USD 177.14KSEC XBRL filing
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-05-21FILINGCURRENT REPORT →
    2026-05-13FILINGQUARTERLY REPORT →
    2026-03-25FILINGANNUAL REPORT →
    2025-11-14FILINGQUARTERLY REPORT →
    2025-11-10FILINGCURRENT REPORT →
    2025-09-23FILINGCURRENT REPORT →
    2025-09-18FILINGCURRENT REPORT →
    2025-09-17FILINGPROSPECTUS →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage